37 unknown. 37 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 37 | Unknown 37 |
Follow Control: new trials by email Literature Review of Control trials Research Report on Control
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect of Noninvasive Ventilation on Physical Activity and Inflammation in COPD Patients Control, NIMV group - Chronic Obstructive Pulmonary Disease, Hypercapnic | Phase 4 | Unknown | Hospital Universitario La Paz | 50 | 2025-12-01 | 2023-03-06 |
| The Effect of Mediclore as an Anti-adhesion Agent and Safety in Full-endoscopic Spine Surgery: a Preliminary Study Mediclore, Normal Saline - Lumbar Disc Disease, Epidural Fibrosis | Phase 4 | Unknown | King Chulalongkorn Memorial Hospital | 78 | 2023-10-01 | 2023-09-14 |
| Diode Laser and Photodynamic Therapy Vs. Ciclopirox. Diode laser combined with photodynamic-red laser therapy by RapidoPodia Laser Diodo®, Ciclopirox Hydroxypropyl Chitosan (HPCH) Nail Lacquer - Onychomycosis | Phase 4 | Unknown | Universidad Complutense de Madrid | 26 | 2023-09-01 | 2023-05-10 |
| A Prospective, Randomized, Controlled Study of rhTPO in Combination With Herombopag + CsA vs Herombopag + CsA for the Treatment of Primary TD-NSAA Herombopag + CsA, rhTPO combined with Herombopag + CsA - Aplastic Anemia, Drug Effect | Phase 4 | Unknown | Peking Union Medical College Hospital | 90 | 2023-08-01 | 2023-08-22 |
| Clinical Trial for GNX80 in Intermittent Claudication GNX80, Placebo - Intermittent Claudication | Phase 4 | Unknown | SK Chemicals Co., Ltd. | 120 | 2022-09-05 | 2022-10-27 |
| Efficacy and Safety of rhTPO's Prophylactic Treatment of CTIT in Patients With High Risk of Cardiac Injury rhTPO, Control - Cancer Treatment Induced Thrombocytopenia | Phase 4 | Unknown | The First Affiliated Hospital of Dalian Medical University | 165 | 2022-06-06 | 2024-03-01 |
| Withdrawal of Pharmacological Treatment in Patients Responding to Cardiac Resynchronization Therapy: Complete removal of pharmacological treatment, Control - Heart Failure | Phase 4 | Unknown | Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia | 60 | 2021-12-03 | 2021-12-30 |
| Intraoperative IV Iron on Postoperative Red Blood Cell Recovery Ferric carboxymaltose, control - Osteoarthritis, Hip | Phase 4 | Unknown | Konkuk University Medical Center | 46 | 2021-03-01 | 2020-08-19 |
| Comparison of Remdesivir Versus Lopinavir/ Ritonavir and Remdesivir Combination in COVID-19 Patients Remdesivir, Lopinavir/ Ritonavir and Remdesivir combination - Covid19 | Phase 4 | Unknown | Ahmed Essam | 90 | 2020-11-01 | 2021-03-17 |
| Does Higher OT Temperature and IV Ondansetron Reduce Incidence of PSS in Parturients? IV Ondansetron 4mg, Higher OT temperature range, Placebo - Temperature Change, Body, Chills | Phase 4 | Unknown | Dr Lim Siu Min | 628 | 2020-10-13 | 2021-10-14 |
| Liposomal Bupivacaine in Benign Soft Tissue Tumor Resection Liposomal bupivacaine, Bupivacaine Hydrochloride - Benign Neoplasm | Phase 4 | Unknown | Samaritan Health Services | 140 | 2020-09-01 | 2021-10-19 |
| Effect of Evolocumab in Patients With Critical Limb Ischemia (Evol-CLI) Evolocumab 140mg/mL Injector 1milliliter (mL) Pen x 3 for a monthly dose of 420 mg for 12 months., Placebo 1 milliliter (mL) Injector Pen x 3 monthly for 12 months - Critical Limb Ischemia | Phase 4 | Unknown | Leonardo Clavijo | 32 | 2020-02-24 | 2020-03-13 |
| Urate Lowering Therapies and Left Ventricular Diastolic Dysfunction Febuxostat 40 mg, Benzbromarone 50mg, Control - Hyperuricemia, Metabolic Syndrome | Phase 4 | Unknown | National Defense Medical Center, Taiwan | 120 | 2020-02-01 | 2020-04-28 |
| Early rhBNP on Myocardial Work in Patients With STEMI rhBNP, Control - ST-Segment Elevated Myocardial Infarction | Phase 4 | Unknown | RenJi Hospital | 200 | 2019-11-30 | 2019-11-08 |
| Early rhBNP on Myocardial Remodeling and Reperfusion in Patients With STEMI rhBNP, Control - ST Segment Elevated Myocardial Infarction | Phase 4 | Unknown | RenJi Hospital | 352 | 2019-06-19 | 2023-06-01 |
| Fibrinogen Concentrate In Children Cardiac Surgery 2 Fibrinogen Concentrate, control - C.Surgical Procedure; Cardiac, Blood Coagulation Disorders | Phase 4 | Unknown | Filomena R B G Galas | 42 | 2019-03-01 | 2019-03-21 |
| Passiflora Extract for Benzodiazepine Withdrawal Passiflora incarnata, Control - Benzodiazepine Withdrawal (Disorder) | Phase 4 | Unknown | Nutricion Medica S.L. | 108 | 2018-09-27 | 2018-12-19 |
| Prevention of Acute Kidney Injury by N-Acetylcystein in Patients Undergone Cardiac Valve Replacement N Acetyl Cysteine, Placebos - Surgery--Complications, Cardiac Valve Disease | Phase 4 | Unknown | University of Sao Paulo General Hospital | 154 | 2018-03-15 | 2018-03-05 |
| Effect of Evolocumab in Functional Status and LDL Oxidation of Patients With Peripheral Arterial Disease Evolocumab 140 mg/mL Subcutaneous Injection 1 milliliter (mL) pre-filled injector Pen x 3 for a monthly dose of 420 mg for 6 months., Placebo 1milliliter (mL) Subcutaneous Injection pre-filled injector Pen x 3 monthly for 6 months. - Peripheral Arterial Disease | Phase 4 | Unknown | Leonardo Clavijo | 86 | 2017-12-14 | 2020-03-12 |
| A Trial to Compare Surgery With Sorafenib for Hepatic Celluler Cancer With Portal Vein Tumor Thrombosis Sorafenib, surgery - Portal Vein Tumor Thrombus | Phase 4 | Unknown | Huazhong University of Science and Technology | 54 | 2016-12-15 | 2017-12-21 |
Showing 20 of 37. Sign in to see all of them.
Intermittent Claudication (2) · Ischemia (2) · Ventricular Remodeling (2) · Acute Coronary Syndrome (1) · Acute Kidney Injury (1) · Afibrinogenemia (1) · Anemia, Aplastic (1) · Back Pain (1) · Blood Coagulation Disorders (1) · Body Temperature Changes (1) · COVID-19 (1) · Chills (1) · Chronic Limb-Threatening Ischemia (1) · Colitis, Ulcerative (1) · Coronary Artery Disease (1)
RenJi Hospital (3) · Chulalongkorn University (2) · Leonardo Clavijo (2) · Seoul National University Hospital (2) · Ahmed Essam (1) · Centre for Endocrinology and Reproductive Medicine, Italy (1) · Dr Lim Siu Min (1) · Filomena R B G Galas (1) · Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia (1) · Guangdong Provincial Hospital of Traditional Chinese Medicine (1) · Guangzhou First People's Hospital (1) · Hannover Medical School (1) · Hospital Universitario La Paz (1) · Huazhong University of Science and Technology (1) · King Chulalongkorn Memorial Hospital (1)
China (6) · Thailand (4) · United States (4) · South Korea (3) · Spain (3) · Taiwan (3) · Brazil (2) · Egypt (1) · Germany (1) · India (1) · Israel (1) · Italy (1) · Malaysia (1) · Turkey (Türkiye) (1)
Leonardo Clavijo, MD, PhD (2) · Talerngsak Kanjanabuch, Assist. Prf. (2) · Bikash Medhi, MD (1) · Chang-Hoon Lee, MD (1) · Cheng-Wei Liu, M.D. (1) · Filomena RG Galas (1) · Francesco Morgia, MS (1) · Guy Lahat, MD (1) · Harn-Shen Chen, MD, PhD (1) · Jun Pu, MD,PhD (1)
PMID 10214567, PMID 11350323, PMID 11812709, PMID 12768180, PMID 16363316, PMID 18285392, PMID 18433676, PMID 20542472, PMID 23162393, PMID 23878437, PMID 24200273, PMID 24951020, PMID 25529851, PMID 25712577, PMID 26482376, PMID 27622717, PMID 27646404, PMID 31111094, PMID 31444917, PMID 32708699, PMID 34352935, PMID 35800997, PMID 36413425, PMID 37732786, PMID 38701881, PMID 38810093, PMID 41024682, PMID 42773919, PMID 7802178, PMID 7943770, PMID 9135361, PMID 9783643